Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening

Abstract

BackgroundEconomic evaluation of newborn screening poses specific methodological challenges. Amongst others, these challenges refer to the use of quality adjusted life years (QALYs) in newborns, and which costs and outcomes need to be considered in a full evaluation of newborn screening programmes. Because of the increasing scale and scope of such programmes, a better understanding of the methods of high-quality economic evaluations may be crucial for both producers/authors and consumers/reviewers of newborn screening-related economic evaluations. The aim of this study was therefore to develop specific guidelines designed to assess and improve the methodological quality of economic evaluations in newborn screening.MethodsTo develop the guidelines, existing guidelines for assessing the quality of economic evaluations were identified through a literature search, and were reviewed and consolidated using a deductive iterative approach. In a subsequent test phase, these guidelines were applied to various economic evaluations which acted as case studies.ResultsThe guidelines for assessing and improving the methodological quality of economic evaluations in newborn screening are organized into 11 categories: “bibliographic details”, “study question and design”, “modelling”, “health outcomes”, “costs”, “discounting”, “presentation of results”, “sensitivity analyses”, “discussion”, “conclusions”, and “commentary”.ConclusionsThe application of the guidelines highlights important issues regarding newborn screening-related economic evaluations, and underscores the need for such issues to be afforded greater consideration in future economic evaluations. The variety in methodological quality detected by this study reveals the need for specific guidelines on the appropriate methods for conducting sound economic evaluations in newborn screening.

The Role of Information Provision in Economic Evaluations of Newborn Bloodspot Screening: A Systematic Review

“…Langer et al [ 34 ], produced a set of guidelines to inform the design and conduct of an economic evaluation of an NBSP, which were then applied to published economic evaluations of NBSP for metabolic diseases up to 2011. The authors concluded that the published evaluations were generally poor at measuring and valuing resource data or considering non-health outcomes.…”

Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme

“…For instance, impacts on families and carers, including future family planning, measuring and valuing quality of life in children, especially those with cognitive disabilities, and estimating the impact on families of incidental findings arising through screening [ 74 – 76 , 80 ]. Not all of these issues are covered by current guidelines on economic evaluation of newborn screening interventions [ 81 ] and further methodological work is required to improve the quality and scope of future economic evaluations.…”

Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis

“…An obvious difference between PKU and CF is that PKU has a highly effective therapy, which can virtually eliminate the most important adverse health outcome of the untreated disorder, whereas CF currently does not. An important determinant of the reliability or robustness of CEA estimates is the quality and consistency of epidemiologic evidence of effectiveness [ 134 , 135 ]. Although there is a high confidence in the nutritional benefits of CF NBS, estimates for other outcomes are less certain.…”